Exicure, Inc. (XCUR)
2.75
-0.10
(-3.51%)
USD |
NASDAQ |
Jun 10, 16:00
3.00
+0.25
(+9.09%)
After-Hours: 20:00
Exicure Shareholders Equity (Quarterly) : 2.098M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 2.098M |
| December 31, 2025 | 3.926M |
| September 30, 2025 | 6.927M |
| June 30, 2025 | 8.863M |
| March 31, 2025 | 11.38M |
| December 31, 2024 | 6.772M |
| September 30, 2024 | 1.545M |
| June 30, 2024 | 1.613M |
| March 31, 2024 | 2.207M |
| December 31, 2023 | 3.031M |
| September 30, 2023 | 4.498M |
| June 30, 2023 | 9.705M |
| March 31, 2023 | 14.62M |
| December 31, 2022 | 14.92M |
| September 30, 2022 | -3.703M |
| June 30, 2022 | 1.163M |
| March 31, 2022 | 3.236M |
| December 31, 2021 | 11.23M |
| Date | Value |
|---|---|
| September 30, 2021 | 13.98M |
| June 30, 2021 | 36.64M |
| March 31, 2021 | 50.04M |
| December 31, 2020 | 61.51M |
| September 30, 2020 | 73.43M |
| June 30, 2020 | 81.75M |
| March 31, 2020 | 85.11M |
| December 31, 2019 | 80.75M |
| September 30, 2019 | 64.95M |
| June 30, 2019 | 11.39M |
| March 31, 2019 | 16.16M |
| December 31, 2018 | 20.95M |
| September 30, 2018 | 25.20M |
| June 30, 2018 | 9.902M |
| March 31, 2018 | 16.31M |
| December 31, 2017 | 19.98M |
| September 30, 2017 | 11.68M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | 114.69M |
| Century Therapeutics, Inc. | 264.74M |
| Absci Corp. | 171.97M |
| Celularity, Inc. | -38.06M |
| Cardio Diagnostics Holdings, Inc. | 8.903M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.76M |
| Total Liabilities (Quarterly) | 10.66M |
| Debt to Equity Ratio | 0.0105 |
| Current Ratio | 0.7919 |
| Net Debt Paydown Yield | 4.36% |